磺胺乙酰胺钠,CAS 登记号 6209-17-2,由济南圣和化工有限公司现货供应,可提供纯度 按批次COA提供(不公开发布) 的规格,下游主要用于无机化学品。支持样品与小批量试用,批量价格请联系我们获取,验收以批次 COA 为准。
无机化学品
每批随货提供 COA;可按需提供 MSDS 及技术文件。邮件注明产品名称与 CAS 号,一个工作日内回复报价。
本页已列出 磺胺乙酰胺钠 的 CAS 号:6209-17-2,可与随货 COA 核对。
常见纯度为 按批次COA提供(不公开发布),包装形式为 按订单/批次确认(不公开发布),特殊规格可在询价时说明。
主要涉及无机化学品。
来信 info@591daili.com 或 WhatsApp 联系,提供产品名称、CAS 号与数量,确认价格与交期后即可安排发货,验收以批次 COA 为准。
Sulfacetamide sodium · CAS 6209-17-2 · C8H11N2NaO4S. UNII 4NRT660KJQ.
| CAS Registry Number | 6209-17-2 |
|---|---|
| PubChem CID | 6419954 |
| Molecular formula | C8H11N2NaO4S |
| IUPAC name | sodium;acetyl-(4-aminophenyl)sulfonylazanide;hydrate |
| UNII (FDA) | 4NRT660KJQ |
| Molecular Weight | 254.24 |
|---|---|
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 2 |
| Exact Mass | 254.03372229 |
| Monoisotopic Mass | 254.03372229 |
| Topological Polar Surface Area | 87.6 |
| Heavy Atom Count | 16 |
| Formal Charge | 0 |
| Complexity | 304 |
| GHS notification summary | 4.5% (2 / 44) |
|---|
| GHS notification summary | 4.5% (2 / 44) |
|---|---|
| Reported hazard statements | H315 (93.2%), H319 (93.2%), H335 (93.2%), H317 (16.7%), H334 (16.7%) |
This chemical does not meet GHS hazard criteria for 4.5% (2 of 44) of reports.
H315 (93.2%): Causes skin irritation [Warning Skin corrosion/irritation]
6209-17-2; Sulfacetamide sodium monohydrate; Sodium sulamyd; Klaron; Bleph; Sulfacetamide sodium salt monohydrate; Ocusulf; Sulfacel; Sodium N-sulfanilylacetamide monohydrate; Sulfair Forte; Sulfacel-15; Ocusulf-10; Sulfair 10; Sulfair-15; Isopto cetamide; Sulten-10
CAS 6209-17-2; molecular formula C8H11N2NaO4S; molecular weight — g/mol.
6209-17-2, Sulfacetamide sodium monohydrate, Sodium sulamyd, Klaron, Bleph, Sulfacetamide sodium salt monohydrate.
4.5% of GHS notifications report no hazard classification (2 of 44).
Facts on this page are taken from PubChem (US National Library of Medicine) and Wikidata. Grade-specific data — assay, moisture, particle size, packaging, shelf life — is issued per batch on the COA and is not published here.